Carbon nanotubes as in vivo bacterial probes

Nature Communications

Volumn 5, Issue , 2014, Pages

  Bardhan, Neelkanth M ^a,b   Ghosh, Debadyuti ^a,b,c   Belcher, Angela M ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CARBON NANOTUBE; COAT PROTEIN; GREEN FLUORESCENT PROTEIN; MOLECULAR PROBE;

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; BACTERIOPHAGE; CARBON; DYE; IMAGING METHOD; INFECTIOUS DISEASE; PROBE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM DETECTION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; IN VIVO STUDY; MOUSE; NONHUMAN; PHANTOM; STAPHYLOCOCCUS AUREUS; VALIDATION STUDY; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; BACTERIUM; CHEMISTRY; CLASSIFICATION; ENDOCARDITIS, BACTERIAL; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; GENETIC PROCEDURES; HUMAN; IMAGE QUALITY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR PROBE; NUDE MOUSE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BIOSENSING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; ESCHERICHIA COLI; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBES; NANOTUBES, CARBON; PHANTOMS, IMAGING; STAPHYLOCOCCUS AUREUS;

EID: 84923354707     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5918     Document Type: Article

References (37)

1. Urdea, M. et al. Requirements for high impact diagnostics in the developing world. Nature 444, 73-79 (2006).
2. Reiber, G. E., Pecoraro, R. E. & Koepsell, T. D. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann. Intern. Med. 117, 97-105 (1992).
3. Lipsky, B. A., Itani, K. & Norden, C. Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 38, 17-24 (2004).
4. Hall, B. G. Predicting the evolution of antibiotic resistance genes. Nat. Rev. Micro. 2, 430-435 (2004).
5. Rennen, H. J., Boerman, O. C., Oyen,W. J. & Corstens, F. H. Imaging infection/ inflammation in the new millennium. Eur. J. Nucl. Med. 28, 241-252 (2001).
6. Bettegowda, C. et al. Imaging bacterial infections with radiolabeled 1-(20-deoxy-20-fluoro-b-D-arabinofuranosyl)-5-iodouracil. Proc. Natl Acad. Sci. USA 102, 1145-1150 (2005).
7. Contag, C. H. et al. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18, 593-603 (1995).
8. Liong, M. et al. Specific pathogen detection using bioorthogonal chemistry and diagnostic magnetic resonance. Bioconjugate Chem. 22, 2390-2394 (2011).
9. Lupetti, A., Welling, M. M., Mazzi, U., Nibbering, P. H. & Pauwels, E.K. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur. J. Nucl. Med. Mol. Imaging 29, 674-679 (2002).
10. Welling, M. M., Paulusma-Annema, A., Balter, H. S., Pauwels, E. K. & Nibbering, P. H. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur. J. Nucl. Med. 27, 292-301 (2000).
11. Nekhotiaeva, N. et al. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 18, 394-396 (2004).
12. Bullok, K. E. et al. Permeation peptide conjugates for in vivo molecular imaging applications. Mol. Imaging 5, 1-15 (2006).
13. Leevy, W. M. et al. Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J. Am. Chem. Soc. 128, 16476-16477 (2006).
14. Leevy, W. M. et al. Noninvasive optical imaging of Staphylococcus aureus bacterial infection in living mice using a bis-dipicolylamine-zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjugate Chem. 19, 686-692 (2008).
15. White, A. G., Gray, B. D., Pak, K. Y. & Smith, B. D. Deep-red fluorescent imaging probe for bacteria. Bioorg. Med. Chem. Lett. 22, 2833-2836 (2012).
16. Ning, X. et al. Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat. Mater. 10, 602-607 (2011).
17. Liu, Z., Tabakman, S., Welsher, K. & Dai, H. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res. 2, 85-120 (2010).
18. Welsher, K., Sherlock, S. P. & Dai, H. Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window. Proc. Natl Acad. Sci. 108, 8943 (2011).
19. Yi, H. et al. M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett. 12, 1176-1183 (2012).
20. Weissleder, R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19, 316-317 (2001).
21. Smith, A. M., Mancini, M. C. & Nie, S. Bioimaging: Second window for in vivo imaging. Nat. Nanotech. 4, 710-711 (2009).
22. Bashkatov, A., Genina, E., Kochubey, V. & Tuchin, V. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J. Phys. Appl. Phys. 38, 2543-2555 (2005).
23. Tamara, L. T. & Suresh, N. T. Optical properties of human skin in the near infrared wavelength range of 1000 to 2000 nm. J. Biomed. Opt. 6, 167-176 (2001).
24. Lim, Y. T. et al. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol. Imaging 2, 50-64 (2003).
25. Hong, G. et al. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat. Med. 18, 1841-1846 (2012).
26. Robinson, J. T. et al. High performance in vivo near-IR (41 mm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res. 3, 779-793 (2010).
27. Dang, X. et al. Virus-templated self-assembled single-walled carbon nanotubes for highly efficient electron collection in photovoltaic devices. Nat. Nanotech. 6, 377-384 (2011).
28. Krag, D. N. et al. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res. 66, 7724-7733 (2006).
29. Kelly, K. A., Waterman, P. & Weissleder, R. In vivo imaging of molecularly targeted phage. Neoplasia N. Y. NY 8, 1011-1018 (2006).
30. Ghosh, D., Kohli, A. G., Moser, F., Endy, D. & Belcher, A. M. Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery. ACS Synth. Biol. 1, 576-582 (2012).
31. Liu, Z. et al. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. 105, 1410-1415 (2008).
32. Singh, R. et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl Acad. Sci. USA 103, 3357-3362 (2006).
33. Lowy, F. D. Staphylococcus aureus infections. New Engl. J. Med. 339, 520-532 (1998).
34. Mylonakis, E. & Calderwood, S. B. Infective endocarditis in adults. New Engl. J. Med. 345, 1318-1330 (2001).
35. Lalani, T. et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 121, 1005-1013 (2010).
36. Panizzi, P. et al. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat. Med. 17, 1142-1146 (2011).
37. Beckett, D., Kovaleva, E. & Schatz, P. J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. Publ. Protein Soc. 8, 921-929 (1999).